AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

Two real-world studies show no increased cardiac risk with the antiseizure medication lamotrigine, contradicting earlier ...

Adults and Kids Urged to Heed Safety Tips when Buying Toys 16 June 2025, Quezon City.  With the start of the academic year ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Vita Warehouse Corp. recalled three vitamin B12 gummy brands sold at ALDI and BJ's due to potential undeclared peanut contamination.

In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news ...

In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news ...

Oregon businesses respond after Consumer Reports finds cancer-causing chemicals in all synthetic braiding hair brands tested.

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

A surprise offer, someone refuses to flip, a plane spills secrets, a task force turns the screws, someone agrees to squeal, ...

AbbVie (NYSE: ABBV) announced the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine in the treatment of newly diagnosed higher-risk myelodysplastic ...

There were several food, product and car recalls for the week of June 9-15 that you might have missed, including recalls for ...